What preoperative glucocorticoid regimen should be administered to an adult patient with primary adrenal insufficiency undergoing surgery, including recommendations for minor versus major procedures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Preoperative Glucocorticoid Management in Primary Adrenal Insufficiency

For adults with primary adrenal insufficiency undergoing surgery, administer hydrocortisone 100 mg IV at induction followed immediately by continuous infusion of 200 mg/24 hours for all procedures requiring general or regional anesthesia, regardless of whether the surgery is classified as minor or major. 1

Intraoperative Protocol

The 2020 UK consensus guidelines from the Association of Anaesthetists, Royal College of Physicians, and Society for Endocrinology provide the definitive framework 1:

  • At induction: Hydrocortisone 100 mg IV bolus
  • Immediately after bolus: Start continuous IV infusion of hydrocortisone 200 mg over 24 hours
  • Alternative to infusion: Hydrocortisone 50 mg IM every 6 hours

This regimen applies uniformly to:

  • Major surgery
  • Minor procedures under anesthesia (including endoscopy, joint reduction, IVF egg extraction)
  • Both general and regional anesthesia

Postoperative Management

While NPO or vomiting: Continue hydrocortisone 200 mg/24h IV infusion (or 50 mg IM every 6 hours) 1

Once tolerating oral intake:

  • Resume oral hydrocortisone at double the usual maintenance dose
  • Continue doubled dose for 48 hours for uncomplicated minor procedures
  • Continue doubled dose for 48 hours to one week following major surgery 1
  • Example: If baseline is 10-5-5 mg hydrocortisone, give 20-10-10 mg postoperatively

Physiologic Rationale

The guidelines base these recommendations on physiologic data showing that uncomplicated major surgery triggers approximately a five-fold increase in cortisol secretion to ~100 mg/day, with plasma cortisol returning to baseline within 24-48 hours 1. The 200 mg/24h infusion mimics this stress response and provides a safety margin for unexpected complications.

Critical Distinction: No "Minor vs Major" Differentiation for Primary AI

Unlike patients on therapeutic steroids (where body surface/intermediate surgery may warrant lower doses), patients with primary adrenal insufficiency receive the same high-dose protocol for all procedures under anesthesia 1. This reflects their complete inability to mount any endogenous cortisol response and the life-threatening risk of adrenal crisis.

Special Considerations

Bowel preparation procedures: Require clinical supervision with consideration of IV fluids and injected glucocorticoid during preparation, especially critical for patients dependent on fludrocortisone or vasopressin 1

Mineralocorticoid replacement: Not required when hydrocortisone dose exceeds 50 mg/24 hours, as this provides adequate mineralocorticoid activity 2. Resume fludrocortisone when returning to maintenance oral dosing.

Common Pitfalls to Avoid

  1. Do not reduce steroid coverage based on "minor" procedure classification - all procedures under anesthesia in primary AI warrant full stress dosing
  2. Do not delay infusion start - begin immediately after the 100 mg bolus at induction
  3. Do not stop stress dosing prematurely - continue until patient is stable, eating, and recovering well
  4. Do not forget patient education - patients with longstanding AI often recognize early signs of under-replacement that ward staff may dismiss 1

Evidence Quality and Controversies

While the 2020 UK guidelines 1 represent the most comprehensive and recent consensus, some controversy exists. A 2012 Cochrane review 3 and 2008 systematic review 4 found insufficient evidence to definitively support or refute supplemental perioperative steroids, noting only 2 small RCTs with high bias risk. However, these studies primarily addressed patients on therapeutic steroids, not those with established primary adrenal insufficiency.

The Endocrine Society 2016 guidelines 2 similarly recommend stress dosing for primary AI based on physiologic principles rather than RCT evidence, acknowledging that "there are no randomized controlled studies evaluating glucocorticoid dose requirements in patients with PAI during times of increased cortisol need."

The consensus prioritizes preventing potentially fatal adrenal crisis over concerns about short-term glucocorticoid excess, as no harm from these perioperative doses has been demonstrated, and the mortality risk from adrenal crisis is 0.5% per crisis event 1.

Monitoring During Recovery

If the patient remains critically ill postoperatively, continue IV stress dosing rather than transitioning to oral doubled doses. Only taper when clinical recovery is evident and the patient is hemodynamically stable without vasopressor support.

References

Related Questions

What is the appropriate perioperative steroid dosing regimen for a patient on chronic prednisone 20 mg daily?
What are the recommended peri‑operative stress‑dose steroid protocols for patients on chronic glucocorticoid therapy or with adrenal insufficiency?
What preoperative recommendations should be followed for a patient with Addison disease (primary adrenal insufficiency) undergoing surgery, including stress-dose glucocorticoid regimen, mineralocorticoid replacement, fluid and electrolyte management, and monitoring?
What is the recommended monitoring plan for a patient with adrenal insufficiency receiving glucocorticoid and mineralocorticoid replacement?
Are corticosteroids (steroids) contraindicated preoperatively?
How should I manage a patient presenting with retro‑auricular pain and temporomandibular joint pain, with no evidence of mastoiditis?
How should I work up an asymptomatic middle-aged man with a prolonged activated partial thromboplastin time greater than twice the upper limit?
Is this amino‑acid supplement a sterile parenteral product intended only for hospital use?
Which medications or substances can cause blue skin discoloration?
What is the appropriate management for a 27-year-old woman presenting with oral ulcer, alopecia, lethargy, anemia, thrombocytopenia, prolonged activated partial thromboplastin time (aPTT), and proteinuria?
How should vomiting caused by digoxin toxicity be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.